<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The number of people with <z:mp ids='MP_0002055'>diabetes</z:mp> and pre-<z:mp ids='MP_0002055'>diabetes</z:mp> are exponentially increasing </plain></SENT>
<SENT sid="1" pm="."><plain>Studies on humans have shown the beneficial effects of Zinc supplementation in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The present study aims to systematically evaluate the literature and meta-analyze the effects of Zinc supplementation on <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>A systematic review of published studies reporting the effects of Zinc supplementations on <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> was undertaken </plain></SENT>
<SENT sid="4" pm="."><plain>The literature search was conducted in the following databases; PubMed, Web of Science and SciVerse Scopus </plain></SENT>
<SENT sid="5" pm="."><plain>A meta-analysis of studies examining the effects of Zinc supplementation on clinical and biochemical parameters in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> was performed </plain></SENT>
<SENT sid="6" pm="."><plain>The total number of articles included in the present review is 25, which included 3 studies on type-1 <z:mp ids='MP_0002055'>diabetes</z:mp> and 22 studies on type-2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>There were 12 studies comparing the effects of Zinc supplementation on fasting blood <z:chebi fb="105" ids="17234">glucose</z:chebi> in patients with type-2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>The pooled mean difference in fasting blood <z:chebi fb="105" ids="17234">glucose</z:chebi> between Zinc supplemented and placebo groups was 18.13mg/dl (95%CI:33.85,2.41; p&lt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>2-h post-prandial blood sugar also shows a similar distinct reduction in (34.87mg/dl [95%CI:75.44; 5.69]) the Zinc treated group </plain></SENT>
<SENT sid="10" pm="."><plain>The reduction in HbA1c was 0.54% (95%CI:0.86;0.21) in the Zinc treated group </plain></SENT>
<SENT sid="11" pm="."><plain>There were 8 studies comparing the effects of Zinc supplementation on <z:chebi fb="23" ids="18059">lipid</z:chebi> parameters in patients with type-2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>The pooled mean difference for total cholesterol between Zinc supplemented and placebo groups was 32.37mg/dl (95%CI:57.39,7.35; p&lt;0.05) </plain></SENT>
<SENT sid="13" pm="."><plain><z:chebi fb="1" ids="47774">Low-density lipoprotein cholesterol</z:chebi> also showed a similar distinct reduction in the Zinc treated group, the pooled mean difference from random effects analysis was 11.19mg/dl (95%CI:21.14,1.25; p&lt;0.05) </plain></SENT>
<SENT sid="14" pm="."><plain>Studies have also shown a significant reduction in systolic and diastolic blood pressures after Zinc supplementation </plain></SENT>
<SENT sid="15" pm="."><plain>This first comprehensive systematic review and meta-analysis on the effects of Zinc supplementation in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> demonstrates that Zinc supplementation has beneficial effects on glycaemic control and promotes healthy <z:chebi fb="23" ids="18059">lipid</z:chebi> parameters </plain></SENT>
<SENT sid="16" pm="."><plain>Further studies are required to identify the exact biological mechanisms responsible for these results </plain></SENT>
</text></document>